CBIO (STOCKS)
Crescent Biopharma, Inc. Common Stock
$9.450000
+0.000000 (+0.00%)
Prev close: $9.450000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Joshua T. Brumm
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $260.69M
- Employees
- 26
- P/E (TTM)
- -0.43
- P/B (TTM)
- 1.17
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
8
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-1.27 | $-2.02 | +0.7516 | +37.18% |
|
Jun 2025 (Q2)
|
$-4.93 | $-1.80 | -3.1322 | -174.22% |
|
Mar 2025 (Q1)
|
$-4.00 | $-5.10 | +1.1000 | +21.57% |
|
Jun 2024 (Q2)
|
$-16.00 | $-17.09 | +1.0850 | +6.35% |